Related Experiment Videos

Evidence for an ascending inhibitory histaminergic pathway to the cerebral cortex

Insights

Metiamide, a histamine antagonist, was tested on rat neurons. It blocked histamine effects and reduced inhibition from medial forebrain bundle stimulation, suggesting a histaminergic pathway influences cortical neuron activity.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Metiamide is a known histamine antagonist in the rat cerebral cortex.
  • Histamine levels and L-histidine decarboxylase activity decrease in the cerebral cortex after medial forebrain bundle (MFB) disruption.

Purpose of the Study:

  • To investigate if metiamide antagonizes neuronal inhibition caused by MFB stimulation.
  • To explore the role of a potential histaminergic pathway in regulating cortical neuronal activity.

Main Methods:

  • Iontophoretic application of histamine and metiamide in anesthetized rats.
  • Stimulation of the medial forebrain bundle (MFB) and cortical surface.
  • Recording of deep cerebral cortical neuronal firing rates.

Main Results:

  • Metiamide antagonized histamine-induced neuronal depression.
  • Metiamide reduced the duration of inhibition following MFB stimulation.
  • Metiamide did not affect inhibition caused by direct cortical surface stimulation.

Conclusions:

  • A histaminergic pathway ascending via the MFB likely inhibits rat cerebral cortical neurons.
  • This study provides evidence for a descending inhibitory histaminergic pathway in the brain.

Related Concept Videos